Ads
related to: acitretin warnings- Safety & Risk Factor Info
View Metabolic Syndrome Risk Info
For a Psoriasis Treatment Option.
- Clinical Studies
Review Clinical Trial Results for
a Plaque Psoriasis Treatment.
- Real-World Data for HCPs
Review Real-World Study Results
For a Psoriasis Treatment Option.
- Safety Info for HCPs
Learn more About Safety Outcomes
For Patients with Scalp Psoriasis
- Safety & Prescribing Info
View Safety & Prescription Info for
a Plaque Psoriasis Treatment.
- Biologic MOA for PsO
Learn More About the MOA for this
Plaque Psoriasis Treatment.
- Safety & Risk Factor Info
Search results
Results From The WOW.Com Content Network
Acitretin, sold under the brand names Neotigason [2] and Soriatane, [5] is a second-generation retinoid.It is taken orally, and is typically used for psoriasis. [6]Acitretin is an oral retinoid used in the treatment of severe resistant psoriasis.
Isotretinoin, also known as 13-cis-retinoic acid and sold under the brand name Accutane among others, is a medication used to treat skin diseases like harlequin-type ichthyosis, and lamellar ichthyosis, and severe cystic acne or moderate acne that is unresponsive to antibiotics. [6]
The basic structure of the hydrophobic retinoid molecule consists of a cyclic end group, a polyene side chain and a polar end group. The conjugated system formed by alternating C=C double bonds in the polyene side chain are responsible for the color of retinoids (typically yellow, orange, or red).
Tretinoin, also known as all-trans retinoic acid (ATRA), is a medication used for the treatment of acne and acute promyelocytic leukemia. [8] [9] [10] For acne, it is applied to the skin as a cream, gel or ointment. [10]
Other drugs which may provide relief include acitretin, ciclosporin, and methotrexate, but since these drugs have their own major side effects, doctors and patients should discuss whether to try one of these or a biologic first. [4] Most biologics are injections so are not appropriate for use by someone with intense fear of needles. [4]
Bexarotene is indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in people who are refractory to at least one prior systemic therapy (oral) and for the topical treatment of cutaneous lesions in patients with CTCL who have refractory or persistent disease after other therapies or who have not tolerated other therapies (topical).
Ad
related to: acitretin warnings